Fibroheal Woundcare
PrivateLast Round
VC Round
Jul 8, 2026
Total Funding Raised
$2.04M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Fibroheal Woundcare operates in Healthcare & Life Sciences and is based in Bangalore. Its latest recorded funding round was a VC Round in July 2026.
Fibroheal Woundcare is a biotechnology company that specializes in developing, manufacturing, and commercializing advanced wound care products derived from silk proteins.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fibroheal Woundcare Comparables
Compare Fibroheal Woundcare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Serigen Mediproducts | 83% | |
| GelSana Therapeutics | 76% | |
| Axio Biosolutions | 75% |
For institutional investors. Book with your work email.
Fibroheal Woundcare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 8, 2026 | ||||
| Early Funding | Dec 15, 2024 | ||||
| Follow-on Offering | Nov 29, 2022 | ||||
| Debt | Mar 17, 2022 | ||||
| VC Round | Sep 19, 2021 | ||||
Grant | Jul 30, 2019 |
For institutional investors. Book with your work email.
Fibroheal Woundcare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startup Karnataka | Grant |
| Biotechnology Industry Research Assistance Council | Debt |
| Karnataka Information Technology Venture Fund | VC Round, Follow-on Offering |
| Centre for Cellular and Molecular Platforms | VC Round |
| Department of Biotechnology | VC Round |
| Telama Investments | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 1243% MoM, reaching 16.6K.
- Jul 30, 2025
Added pamela Tracy, a startup in the healthcare sector.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingNov 2, 2026
Fibroheal raises a total of $3.8M across nine rounds, including seven Seed rounds, one Debt round, and one Grant round, as of Nov '26.
For institutional investors. Book with your work email.
Fibroheal Woundcare Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fibroheal Woundcare's valuation, stock price, and market status.
Is Fibroheal Woundcare a public or private company?
Fibroheal Woundcare is a private company.
What is the current stock price of Fibroheal Woundcare?
Fibroheal Woundcare is a private company, so its shares have no public market price. Caplight tracks Fibroheal Woundcare's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fibroheal Woundcare worth (valuation)?
Valuation information for Fibroheal Woundcare is not publicly available.
Can I buy Fibroheal Woundcare stock?
Fibroheal Woundcare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fibroheal Woundcare's last funding round?
Fibroheal Woundcare's most recent funding round was VC Round on July 8, 2026.
Who are the main investors in Fibroheal Woundcare?
Key investors in Fibroheal Woundcare include Biotechnology Industry Research Assistance Council, Karnataka Information Technology Venture Fund.
Will Fibroheal Woundcare IPO soon?
No public IPO plans have been announced for Fibroheal Woundcare.
How can I track Fibroheal Woundcare secondary market activity?
Caplight tracks bids, offers, and trades in Fibroheal Woundcare's shares on secondary markets.